Accretive Health
AH
AH was delisted on the 14th of March, 2014.
66 hedge funds and large institutions have $404M invested in Accretive Health in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 34 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
132% more call options, than puts
Call options by funds: $755K | Put options by funds: $325K
10% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 20
15% less capital invested
Capital invested by funds: $476M → $404M (-$72.7M)
22% less funds holding
Funds holding: 85 → 66 (-19)
53% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Indaba Capital Management
San Francisco,
California
|
+$32M |
| 2 |
MCO
MAK Capital One
New York
|
+$22.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.6M |
| 4 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$14.6M |
| 5 |
AC
Amici Capital
New York
|
+$10.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$27.2M |
| 2 |
D.E. Shaw & Co
New York
|
-$19.3M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$14.2M |
| 4 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
-$13.7M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$13.7M |
AH Hedge Fund Activity: Q1 2014 in Review
66 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q1 2014, worth a combined $404M — down 15% from $476M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of AH and 16 opened new positions — a net loss of 18 holders — while 20 trimmed existing stakes and 22 added.
The largest buyer was Indaba Capital Management, opening a new position worth an estimated $32M. The largest seller was Vanguard Group, exiting entirely with an estimated $27.2M sold.
- 66 institutional investors held Accretive Health (AH) as of Q1 2014, down from 85 in Q4 2013.
- Funds reported $404M of Accretive Health stock for Q1 2014, down 15% quarter-over-quarter.
- 16 funds opened new Accretive Health positions in Q1 2014 and 34 closed out, a net change of -18 holders.
- The largest Accretive Health buyer in Q1 2014 was Indaba Capital Management, an estimated $32M added.
- The largest Accretive Health seller in Q1 2014 was Vanguard Group, an estimated $27.2M sold.
Based on aggregated 13F filings for Q1 2014.